Anton Camacho

机构：Epicentre (South Africa) · ORCID：0000-0002-0023-3985

发表论文 77 篇 · 总被引 4589 次 · h-index 28

代表论文

• Effectiveness of rVSV-ZEBOV vaccination during the 2018–20 Ebola virus disease epidemic in the Democratic Republic of the Congo: a retrospective test-negative study (2024 · The Lancet Infectious Diseases · 被引 51)
• A prospective, multi-site, cohort study to estimate incidence of infection and disease due to Lassa fever virus in West African countries (the Enable Lassa research programme)–Study protocol (2023 · PLoS ONE · 被引 28)
• Importance of investing time and money in integrating large language model-based agents into outbreak analytics pipelines (2024 · The Lancet Microbe · 被引 8)
• Delivery and Safety of a Two-Dose Preventive Ebola Virus Disease Vaccine in Pregnant and Non-Pregnant Participants during an Outbreak in the Democratic Republic of the Congo (2024 · Vaccines · 被引 6)
• rVSV-ZEBOV vaccination in people with pre-existing immunity to Ebolavirus: an open-label safety and immunogenicity study in Guinean communities affected by Ebola virus disease (l’essai proches) (2024 · BMC Medicine · 被引 4)
• Health-economic impacts of age-targeted and sex-targeted Lassa fever vaccination in endemic regions of Nigeria, Guinea, Liberia, and Sierra Leone: a modelling study (2026 · The Lancet Global Health · 被引 3)